Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders

Cold Spring Harbor Perspectives in Medicine

Volumn 4, Issue 10, 2014, Pages

  Prendiville, Terence ^a   Jay, Patrick Y ^b   Pu, William T ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX1; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG; GATA4 PROTEIN, HUMAN; GATA4 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; NKX2-5 PROTEIN, HUMAN; NKX2-5 PROTEIN, MOUSE; T-BOX TRANSCRIPTION FACTOR 5; TBX1 PROTEIN, HUMAN; TBX1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ARTICLE; CONGENITAL HEART DISEASE; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENE MUTATION; GENETIC VARIABILITY; HEART DEVELOPMENT; HEREDITY; HETEROZYGOTE; HUMAN; MISSENSE MUTATION; MODIFIER GENE; MONOGENIC DISORDER; MURINAE; NONHUMAN; PATHOGENESIS; PENETRANCE; PHENOTYPIC VARIATION; ANIMAL; CONGENITAL HEART MALFORMATION; GENETICS; HEART DISEASES; MOUSE; MUTATION; PHENOTYPE;

MURINAE; MUS;

ANIMALS; GATA4 TRANSCRIPTION FACTOR; HEART DEFECTS, CONGENITAL; HEART DISEASES; HOMEODOMAIN PROTEINS; HUMANS; MICE; MUTATION; PHENOTYPE; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS;

EID: 84923804091     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a013946     Document Type: Article

References (103)

1. Basson CT, Cowley GS, Solomon SD, Weissman B, Poznanski AK, Traill TA, Seidman JG, Seidman CE. 1994. The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 330: 885-891.
2. Beffagna G, Cecchetto A, Dal Bianco L, Lorenzon A, Angelini A, Padalino M, Vida V, Bhattacharya S, Stellin G, Rampazzo A, et al. 2012. R25C mutation in the NKX2.5 gene in Italian patients affected with non-syndromic and syndromic congenital heart disease. J Cardiovasc Med (Hagerstown) 14: 582-586.
3. Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, Zhang Y, Riggs S, Smalls O, Johnson MC, Watson MS, Seidman JG, et al. 1999. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104: 1567-1573.
4. Biben C, Weber R, Kesteven S, Stanley E, McDonald L, Elliott DA, Barnett L, Koentgen F, Robb L, Feneley M, et al. 2000. Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 87: 888-895.
5. Bisping E, Ikeda S, Kong SW, Tarnavski O, Bodyak N, McMullen JR, Rajagopal S, Son JK, Ma Q, Springer Z, et al. 2006. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overloadinduced heart failure. Proc Natl Acad Sci 103: 14471-14476.
6. Brassington AM, Sung SS, Toydemir RM, Le T, Roeder AD, Rutherford AE, Whitby FG, Jorde LB, Bamshad MJ. 2003. Expressivity ofHolt-Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet 73: 74-85.
7. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, et al. 2001. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106: 709-721.
8. Chen MW, Pang YS, Guo Y, Pan JH, Liu BL, Shen J, Liu TW. 2010a. GATA4 mutations in Chinese patients with congenital cardiac septal defects. Pediatr Cardiol 31: 85-89.
9. Chen Y, Han ZQ, Yan WD, Tang CZ, Xie JY, Chen H, Hu DY. 2010b. A novel mutation in GATA4 gene associated with dominant inherited familial atrial septal defect. J Thorac Cardiovasc Surg 140: 684-687.
10. Chen Y, Mao J, Sun Y, Zhang Q, Cheng HB, Yan WH, Choy KW, Li H. 2010c. A novel mutation of GATA4 in a familial atrial septal defect. Clin Chim Acta 411: 1741-1745.
11. D’Amato E, Giacopelli F, Giannattasio A, D’Annunzio G, Bocciardi R, Musso M, Lorini R, Ravazzolo R. 2010. Genetic investigation in an Italian child with an unusual association of atrial septal defect, attributable to a new familialGATA4 gene mutation, and neonatal diabetes due to pancreatic agenesis. Diabet Med 27: 1195-1200.
12. Dolk H, Loane M, Garne E. 2011. Congenital heart defects in Europe: Prevalence and perinatal mortality, 2000 to 2005. Circulation 123: 841-849.
13. Elliott DA, Kirk EP, Yeoh T, Chandar S, McKenzie F, Taylor P, Grossfeld P, Fatkin D, Jones O, Hayes P, et al. 2003. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol 41: 2072-2076.
14. Fahed AC, Gelb BD, Seidman JG, Seidman CE. 2013. Genetics of congenital heart disease: The glass half empty. Circ Res 112: 707-720.
15. Ferencz C, Boughman JA, Neill CA, Brenner JI, Perry LW. 1989. Congenital cardiovascular malformations: Questions on inheritance. Baltimore-Washington Infant Study Group. J Am Coll Cardiol 14: 756-763.
16. Flatt T. 2005. The evolutionary genetics of canalization. Q Rev Biol 80: 287-316.
17. Friedberg MK, Silverman NH, Moon-Grady AJ, Tong E, Nourse J, Sorenson B, Lee J, Hornberger LK. 2009. Prenatal detection of congenital heart disease. J Pediatr 155: 26-31, 31.e1.
18. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, et al. 2003. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447.
19. Gill HK, Splitt M, Sharland GK, Simpson JM. 2003. Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol 42: 923-929.
20. Gioli-Pereira L, Pereira AC, Mesquita SM, Xavier-Neto J, Lopes AA, Krieger JE. 2010. NKX2.5 mutations in patients with non-syndromic congenital heart disease. Int J Cardiol 138: 261-265.
21. Glauser TA, Zackai E, Weinberg P, Clancy R. 1989. Holt-Oram syndrome associatedwith the hypoplastic left heart syndrome. Clin Genet 36: 69-72.
22. Goldmuntz E, Geiger E, Benson DW. 2001. NKX2.5 mutations in patients with tetralogy of fallot. Circulation 104: 2565-2568.
23. Goodship J, Cross I, LiLing J, Wren C. 1998. A population study of chromosome 22q11 deletions in infancy. Arch Dis Child 79: 348-351.
24. Granados-Riveron JT, Pope M, Bu’lock FA, Thornborough C, Eason J, Setchfield K, Ketley A, Kirk EP, Fatkin D, Feneley MP, et al. 2012. Combined mutation screening of NKX2-5, GATA4, and TBX5 in congenital heart disease: Multiple heterozygosity and novel mutations. Congenit Heart Dis 7: 151-159.
25. Gutierrez-Roelens I, Sluysmans T, Gewillig M, Devriendt K, Vikkula M. 2002. Progressive AV-block and anomalous venous return among cardiac anomalies associated with two novel missense mutations in the CSX/NKX2-5 gene. Hum Mutat 20: 75-76.
26. Hamanoue H, Rahayuningsih SE, Hirahara Y, Itoh J, Yokoyama U, Mizuguchi T, Saitsu H, Miyake N, Hirahara F, Matsumoto N. 2009. Genetic screening of 104 patients with congenitally malformed hearts revealed a fresh mutation ofGATA4 in thosewith atrial septal defects. Cardiol Young 19: 482-485.
27. Harris IS. 2011. Management of pregnancy in patients with congenital heart disease. Prog Cardiovasc Dis 53: 305-311.
28. Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, Nakamura Y, Tomita H, Furutani M, Imamura S, Takao A, Nakazawa M, et al. 2005. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A 135: 47-52.
29. Ikeda Y, Hiroi Y, Hosoda T, Utsunomiya T, Matsuo S, Ito T, Inoue J, Sumiyoshi T, Takano H, Nagai R, et al. 2002. Novel point mutation in the cardiac transcription factor CSX/NKX2.5 associated with congenital heart disease. Circ J 66: 561-563.
30. Jay PY, Harris BS, Buerger A, Rozhitskaya O, Maguire CT, Barbosky LA, McCusty E, Berul CI, O’brien TX, Gourdie RG, et al. 2004a. Function follows form: Cardiac conduction system defects in Nkx2-5 mutation. Anat Rec A Discov Mol Cell Evol Biol 280: 966-972.
31. Jay PY, Harris BS, Maguire CT, Buerger A, Wakimoto H, Tanaka M, Kupershmidt S, Roden DM, Schultheiss TM, O’Brien TX, et al. 2004b. Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest 113: 1130-1137.
32. Jerome LA, Papaioannou VE. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 27: 286-291.
33. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. 2010. Changing mortality in congenital heart disease. J Am Coll Cardiol 56: 1149-1157.
34. Kodo K, Nishizawa T, Furutani M, Arai S, Ishihara K, Oda M, Makino S, Fukuda K, Takahashi T, Matsuoka R, et al. 2012. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects. Circ J 76: 1703-1711.
35. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C, Leiden JM. 1997. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 11: 1048-1060.
36. Li H, Cherry S, Klinedinst D, DeLeon V, Redig J, Reshey B, Chin MT, Sherman SL, Maslen CL, Reeves RH. 2012. Genetic modifiers predisposing to congenital heart disease in the sensitized Down syndrome population. Circ Cardiovasc Genet 5: 301-308.
37. Lindsay EA. 2001. Chromosomal microdeletions: Dissecting del22q11 syndrome. Nat Rev Genet 2: 858-868.
38. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ, et al. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410: 97-101.
39. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. 1993. Nkx-2.5: A novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119: 969.
40. Liu XY, Yang YQ, Ma J, Lin XP, Zheng JH, Bai K, Chen YH. 2010. Novel GATA4 mutations identified in patients with congenital atrial septal defects. Zhonghua Xin Xue Guan Bing Za Zhi 38: 724-727.
41. Liu XY, Wang J, Zheng JH, Bai K, Liu ZM, Wang XZ, Liu X, Fang WY, Yang YQ. 2011. Involvement of a novel GATA4 mutation in atrial septal defects. Int JMol Med 28: 17-23.
42. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. 1995. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9: 1654-1666.
43. Maslen CL, Babcock D, Robinson SW, Bean LJ, Dooley KJ, Willour VL, Sherman SL. 2006. CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. AmJMed Genet A 140: 2501-2505.
44. McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. 2003. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42: 1650-1655.
45. Molkentin JD, Lin Q, Duncan SA, Olson EN. 1997. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 11: 1061-1072.
46. Mori AD, Bruneau BG. 2004. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr Opin Cardiol 19: 211-215.
47. Mori AD, Zhu Y, Vahora I, Nieman B, Koshiba-Takeuchi K, Davidson L, Pizard A, Seidman JG, Seidman CE, Chen XJ, et al. 2006. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Dev Biol 297: 566-586.
48. Nemer G, Fadlalah F, Usta J, Nemer M, Dbaibo G, Obeid M, Bitar F. 2006. A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat 27: 293-294.
49. Newbury-Ecob RA, Leanage R, Raeburn JA, Young ID. 1996. Holt-Oram syndrome: A clinical genetic study. J Med Genet 33: 300-307.
50. Nora JJ. 1968. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases. The genetic-environmental interaction. Circulation 38: 604-617.
51. Okubo A, Miyoshi O, Baba K, Takagi M, Tsukamoto K, Kinoshita A, Yoshiura K, Kishino T, Ohta T, Niikawa N, et al. 2004. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 41: e97.
52. Ouyang P, Saarel E, Bai Y, Luo C, Lv Q, Xu Y, Wang F, Fan C, Younoszai A, Chen Q, et al. 2011. A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden death. Clin Chim Acta 412: 170-175.
53. Pabst S, Wollnik B, Rohmann E, Hintz Y, Glanzer K, Vetter H, Nickenig G, Grohe C. 2008. A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease. Clin Res Cardiol 97: 39-42.
54. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradervand S, Evans SM, Clark B, Feramisco JR, Giles W, et al. 2004. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117: 373-386.
55. Patel C, Silcock L, McMullan D, Brueton L, Cox H. 2012. TBX5 intragenic duplication: A family with an atypical Holt-Oram syndrome phenotype. Eur J Hum Genet 20: 863-869.
56. Pehlivan T, Pober BR, Brueckner M, Garrett S, Slaugh R, Van Rheeden R, Wilson DB, Watson MS, Hing AV. 1999. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am J Med Genet 83: 201-206.
57. Peng T, Wang L, Zhou SF, Li X. 2010. Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica 138: 1231-1240.
58. Pikkarainen S, Tokola H, Kerkela R, Ruskoaho H. 2004. GATA transcription factors in the developing and adult heart. Cardiovasc Res 63: 196-207.
59. Posch MG, Perrot A, Schmitt K, Mittelhaus S, Esenwein EM, Stiller B, Geier C, Dietz R, Gessner R, Ozcelik C, et al. 2008.Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A 146: 251-253.
60. Prall OW, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, Bajolle F, Biben C, McBride JJ, Robertson BR, Chaulet H, et al. 2007. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128: 947-959.
61. Rajagopal SK, Ma Q, Obler D, Shen J, Manichaikul A, Tomita-Mitchell A, Bardman K, Briggs C, Garg V, Srivastava D, et al. 2007. Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol 43: 677-685.
62. Rauch R, Hofbeck M, Zweier C, Koch A, Zink S, Trautmann U, Hoyer J, Kaulitz R, Singer H, Rauch A. 2010. Comprehensive genotype-phenotype analysis in 230 patients with tetralogy of Fallot. J Med Genet 47: 321-331.
63. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. 2008. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 153: 807-813.
64. Rivera-Feliciano J, Lee KH, Kong SW, Rajagopal S, Ma Q, Springer Z, Izumo S, Tabin CJ, Pu WT. 2006. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 133: 3607-3618.
65. Robinson SW, Morris CD, Goldmuntz E, Reller MD, Jones MA, Steiner RD, Maslen CL. 2003. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet 72: 1047-1052.
66. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al. 2012. Executive summary: Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 125: 188-197.
67. Ruzic B, Bosnar B, Beleznay O. 1981. An unusual type of congenital heart disease associated with the Holt-Oramsyndrome (author’s transl). Radiologe 21: 296-299.
68. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B, Prieur M, et al. 1997. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study. J Med Genet 34: 798-804.
69. Sahn DJ, Goldberg SJ, Allen HD, Canale JM. 1981. Crosssectional echocardiographic imaging of supracardiac total anomalous pulmonary venous drainage to a vertical vein in a patient with Holt-Oram syndrome. Chest 79: 113-115.
70. Sarkozy A, Conti E, Neri C, D’Agostino R, Digilio MC, Esposito G, Toscano A, Marino B, Pizzuti A, Dallapiccola B. 2005. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 42: e16.
71. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. 1998. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111.
72. Smith AT, Sack GH Jr, Taylor GJ. 1979. Holt-Oram syndrome. J Pediatr 95: 538-543.
73. Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN. 1997. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet 16: 154-160.
74. Stallmeyer B, Fenge H, Nowak-Gottl U, Schulze-Bahr E. 2010. Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. Clin Genet 78: 533-540.
75. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S. 1999. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126: 1269-1280.
76. Tanaka M, Berul CI, Ishii M, Jay PY, Wakimoto H, Douglas P, Yamasaki N, Kawamoto T, Gehrmann J, Maguire CT, et al. 2002.A mouse model of congenital heart disease: Cardiac arrhythmias and atrial septal defect caused by haploinsufficiency of the cardiac transcription factor Csx/Nkx2.5. Cold Spring Harb Symp Quant Biol 67: 317-325.
77. Tang ZH, Xia L, Chang W, Li H, Shen F, Liu JY, Wang Q, Liu MG. 2006. Two novel missense mutations of GATA4 gene in Chinese patients with sporadic congenital heart defects. Zhonghua YiXue Yi ChuanXue Za Zhi 23: 134-137.
78. Thal S, Boyella R, Arsanjani R, Thai H, Juneman E, Movahed MR, Goldman S. 2012. Unusual combination of Holt-Oram syndrome and persistent left superior vena cava. Congenit Heart Dis 7: E46-E49.
79. Tomita-Mitchell A, Maslen CL, Morris CD, Garg V, Goldmuntz E. 2007. GATA4 sequence variants in patients with congenital heart disease. J Med Genet 44: 779-783.
80. Vincent MC, Heitz F, Tricoire J, Bourrouillou G, Kuhlein E, Rolland M, Calvas P. 1999. 22q11 deletion in DGS/VCFS monozygotic twins with discordant phenotypes. Genet Couns 10: 43-49.
81. Waddington CH. 1942. Canalization of development and the inheritance of acquired characters. Nature 150: 563-565.
82. Wang J, Li XM, Xin YF, Wang LJ, Xu WJ, Hu DY. 2010. Genetic screening for novel GATA4 mutations associated with congenital atrial septal defect. Zhonghua Xin Xue Guan Bing Za Zhi 38: 429-434.
83. Wang J, Fang M, Liu XY, Xin YF, Liu ZM, Chen XZ, Wang XZ, Fang WY, Liu X, Yang YQ. 2011a. A novel GATA4 mutation responsible for congenital ventricular septal defects. Int J Mol Med 28: 557-564.
84. Wang J, Liu XY, Yang YQ. 2011b. Novel NKX2-5 mutations responsible for congenital heart disease. Genet Mol Res 10: 2905-2915.
85. Wang J, Lu Y, Chen H, Yin M, Yu T, Fu Q. 2011c. Investigation of somatic NKX2-5, GATA4 and HAND1 mutations in patients with tetralogy of Fallot. Pathology 43: 322-326.
86. Wang J, Xin YF, Liu XY, Liu ZM, Wang XZ, Yang YQ. 2011d. A novel NKX2-5 mutation in familial ventricular septal defect. Int J Mol Med 27: 369-375.
87. Wang E, Sun S, Qiao B, Duan W, Huang G, An Y, Xu S, Zheng Y, Su Z, Gu X, et al. 2013. Identification of functional mutations in GATA4 in patients with congenital heart disease. PLoS ONE 8: e62138.
88. Wessels MW, Willems PJ. 2010. Genetic factors in non-syndromic congenital heart malformations. Clin Genet 78: 103-123.
89. Whittemore R, Wells JA, Castellsague X. 1994. A secondgeneration study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol 23: 1459-1467.
90. Winston JB, Erlich JM, Green CA, Aluko A, Kaiser KA, Takematsu M, Barlow RS, Sureka AO, LaPage MJ, Janss LL, et al. 2010. Heterogeneity of genetic modifiers ensures normal cardiac development. Circulation 121: 1313-1321.
91. Winston JB, Schulkey CE, Chen IB, Regmi SD, Efimova M, Erlich JM, Green CA, Aluko A, Jay PY. 2012. Complex trait analysis of ventricular septal defects caused by Nkx2-5 mutation. Circ Cardiovasc Genet 5: 293-300.
92. Xiong F, Li Q, Zhang C, Chen Y, Li P, Wei X, Zhou W, Li L, Shang X, Xu X. 2013. Analyses of GATA4, NKX2.5, and TFAP2B genes in subjects from southern China with sporadic congenital heart disease. Cardiovasc Pathol 22: 141-145.
93. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S, et al. 2003. Role of TBX1 in human del22q11.2 syndrome. Lancet 362: 1366-1373.
94. Yamagishi H, Ishii C, Maeda J, Kojima Y, Matsuoka R, Kimura M, Takao A, Momma K, Matsuo N. 1998. Phenotypic discordance in monozygotic twins with 22q11.2 deletion. Am J Med Genet 78: 319-321.
95. Yang YQ, Tang YQ, Liu XY, Lin XP, Chen YH. 2010. A novel GATA4 mutation leading to congenital ventricular septal defect. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 27: 512-516.
96. Yang YQ, Li L, Wang J, Liu XY, Chen XZ, Zhang W, Wang XZ, Jiang JQ, Liu X, Fang WY. 2012a. A novel GATA4 loss-offunction mutation associated with congenital ventricular septal defect. Pediatr Cardiol 33: 539-546.
97. Yang YQ, Wang J, Liu XY, Chen XZ, Zhang W, Wang XZ, Liu X, Fang WY. 2012b. Novel GATA4 mutations in patients with congenital ventricular septal defects. Med Sci Monit 18: CR344-CR350.
98. Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD, Romano-Adesman A, Bjornson RD, Breitbart RE, Brown KK, et al. 2013. De novo mutations in histone-modifying genes in congenital heart disease. Nature 498: 220-223.
99. Zeisberg EM, Ma Q, Juraszek AL, Moses K, Schwartz RJ, Izumo S, Pu WT. 2005. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest 115: 1522-1531.
100. Zhang Z, Baldini A. 2008. In vivo response to high-resolution variation of Tbx1 mRNA dosage. Hum Mol Genet 17: 150-157.
101. Zhang W, Li X, Shen A, Jiao W, Guan X, Li Z. 2008. GATA4 mutations in 486 Chinese patients with congenital heart disease. Eur J Med Genet 51: 527-535.
102. Zhang WM, Li XF, Ma ZY, Zhang J, Zhou SH, Li T, Shi L, Li ZZ. 2009. GATA4 and NKX2.5 gene analysis in Chinese Uygur patients with congenital heart disease. Chin Med J (Engl) 122: 416-419.
103. Zhou P, He A, Pu WT. 2012. Regulation of GATA4 transcriptional activity in cardiovascular development and disease. Curr Top Dev Biol 100: 143-169.